The aim of this project was to profile the proteome of mouse-derived serum in order to identify those that showed significant quantitative different proteins among ALI mice and controls.
Quantitative proteomic analysis of plasma from different time courses of fatal, severe, and mild COVID-19 patients was performed to assess the biological changes during treatment.